Patients with alopecia universalis and alopecia totalis are at a particularly high risk of cardiovascular disease, a new ...

New drugs aren't the only advances in oncology. Innovation includes collaboration between to remove barriers to remove ...

Emerging data suggest that isatuximab‐KRd and daratumumab‐KRd produce superior depth of response compared with KRd alone, with sustained MRD negativity and encouraging progression‐free survival in ...

Patients with myeloproliferative neoplasms (MPNs) appear to be at a higher risk of heart failure and pulmonary hypertension, ...

Telomere length can be used in the diagnosis of interstitial lung diseases like idiopathic pulmonary fibrosis, but it likely ...

Men fared better under surveillance, while women benefited more from targeted therapies for the treatment of chronic ...

Ravi Vij, MD, MBA, discusses the logistical differences between administering CAR T-cell therapy and bispecific antibodies, and how emerging CAR T technologies could affect patient access.

The American Society for Preventive Cardiology (ASPC) marked its 40th anniversary this year at the ASPC Congress on CVD ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

Couples that were made up of 2 transgender women were less likely to contract HIV compared with couples that were made up of ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Jonathan Thompson, MD, MS, explains that adjuvant immunotherapy benefits patients with early-stage lung cancer with incomplete neoadjuvant response, while treatment decisions in the adjuvant setting ...